AQP1 and polycystic kidney disease: In previous studies, AQP1 was demonstrated to be involved in other pathophysiologic mechanisms, such as tumor development, inflammatory cytokines release (via NF-Κb signaling pathway), and polycystic kidney disease (via Wnt signaling pathway) [55,56,57].